Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
ProQR Therapeutics NV | PRQR | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.96 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 1.11 - 3.29 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 1.96 | USD |
ProQR Therapeutics NV Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
159.46M | 81.35M | - | 6.59M | -28.12M | -0.35 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ProQR Therapeutics NV News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRQR Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.90 | 2.12 | 1.84 | 1.99 | 141,591 | 0.06 | 3.16% |
1 Month | 2.26 | 2.46 | 1.81 | 2.09 | 165,543 | -0.30 | -13.27% |
3 Months | 2.17 | 2.70 | 1.81 | 2.13 | 207,739 | -0.21 | -9.68% |
6 Months | 1.23 | 3.29 | 1.11 | 2.05 | 261,652 | 0.73 | 59.35% |
1 Year | 2.24 | 3.29 | 1.11 | 1.87 | 264,241 | -0.28 | -12.50% |
3 Years | 6.18 | 9.09 | 0.53 | 2.83 | 809,861 | -4.22 | -68.28% |
5 Years | 11.23 | 13.28 | 0.53 | 4.52 | 744,825 | -9.27 | -82.55% |
ProQR Therapeutics NV Description
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. |